Swiss dermatology firm Galderma agreed to acquire US-based ZO Skin Health in an all-cash deal valued at $1.5 billion including debt. The acquisition from shareholders including Blackstone Inc. and the founding Obagi family expands Galderma's US footprint and physician-dispensed portfolio, joining its Alastin Skincare brand. ZO Skin Health recorded $330 million in net sales for the year through June 2026. The transaction is slated to close in late 2026 or early 2027, subject to regulatory approvals.
Strategic rationale for Galderma
- ▪Strategic buyers prioritize physician-distributed skincare brands like ZO Skin Health due to their reported efficacy and steadier demand relative to over-the-counter products
- ▪Galderma's acquisition of ZO Skin Health expands Galderma's presence in the United States market and strengthens its physician-dispensed dermatological skincare portfolio
- ▪Galderma's acquisition combines ZO Skin Health with Galderma's existing Alastin Skincare brand within Galderma's premium skincare portfolio
ZO Skin Health background and performance
- ▪Irvine, California-based ZO Skin Health was founded in 2007 by dermatologist Zein Obagi and manufactures products including cleansers, serums, exfoliators, and toners
- ▪ZO Skin Health generated net sales of approximately $330 million in the twelve months ending June 2026
Blackstone ownership and sale process
- ▪Galderma is purchasing ZO Skin Health from shareholders that include investment firm Blackstone Inc., the founding Obagi family, and other shareholders
- ▪Prior to Galderma's deal announcement on October 14, 2026, Blackstone explored a sale of ZO Skin Health with investment banks Citigroup and Raymond James
- ▪Investment firm Blackstone acquired a majority stake in ZO Skin Health through its tactical opportunities fund in 2020
Galderma's history and expansion
- ▪In August 2026, Galderma opened a United States and Latin America headquarters in Miami
- ▪Galderma was founded in 1981, owns brands including Cetaphil, Alastin Skincare, Differin Epiduo, Dysport, and Restylane, and is 20% owned by L'Oréal
Story comments
Loading comments…